See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621443_2018_Zynerba_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001621443, Zynerba Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 68,227,582 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 164,527 |
| 3 | remainder_Assets | 662,200 |
| 4 | LiabilitiesCurrent | 7,442,721 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 662,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,016,902 |
| 9 | ResearchAndDevelopmentExpense | 22,806,107 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 810,705 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 69,054,309 |
| 1 | Liabilities | 8,104,721 |
| 2 | Expenses | 32,823,009 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 60,949,588 |
| 5 | NetIncome | -32,012,304 |
| 6 | ComprehensiveNetIncome | -32,012,304 |
| 7 | BaseVar | 55,396,372 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.61 |
| 9 | EconomicCapitalRatio | 3.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
